University of Queensland-based contract research organisation TetraQ is now recognised to provide internationally accredited testing services to the Australian biopharmaceutical industry.

DNA polymerase epsilon has a critical role in DNA replication, researchers find. [ + ]

All Australian patents are now freely searchable. [ + ]

Mesenchymal tem cells taken from fat tissue used to treat colon cancer. [ + ]

Monash uni is the first organisation outside of Europe to be given associate membership of EMBL. [ + ]

Mass spectrometry expert appointed new CEO of the Australian Research Council. [ + ]

An ambitious international effort has been launched to decode the genome of Eucalyptus, one of the world's most valuable fibre- and paper-producing trees - with the goal to maximise its potential in the burgeoning bio energy market and for capturing excess atmospheric carbon.

Following a decision by the European Molecular Biology Laboratory (EMBL) Council, Australia is set to be granted Associate Membership of EMBL.

NIH-funded trial of Starpharma's VivaGel microbicide under way in US. [ + ]

$331 million deal sees Roche move into RNAi-based therapeutics. [ + ]

New evidence supports theory that a breakdown in frontal temporal connectivity underlies schizophrenia. [ + ]

Professor Nicholas Fisk will head UQ's new clinical research centre. [ + ]

Rio Tinto has announced major funding for one of the world's largest civilian robotics research centres, a centre for mining automation, which will be based at The University of Sydney.

The self professed ‘mammal lady’, who controversially claimed through her comparative genomics research that the male determining Y chromosome will become extinct, has been named Australian Thinker of the Year.

ANSTO and Siemens will build a $10 million nuclear medicine facility in Sydney. [ + ]